Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1989-10-20
|
pubmed:abstractText |
B cell activation is a well known consequence of HIV-1 infection, and seropositive subjects show high numbers of spontaneously activated Ig-secreting cells in circulation. To better define the importance of the HIV-1-specific response in this phenomenon, we first studied whether in vitro spontaneous anti-HIV-1 antibody production was accompanied by reactivation of memory B lymphocytes. Unstimulated PBL from HIV-1-infected individuals with prior history of hepatitis B and/or EBV infection did not consistently show spontaneous in vitro synthesis of anti-hepatitis B core Ag or anti-EBV antibodies; in addition, PWM-induced synthesis of anti-hepatitis B virus and anti-EBV antibodies was decreased compared to HIV-1-seronegative subjects. Moreover, in comparing the frequencies of activated HIV-1-specific B cell precursors and activated Ig-secreting precursors in limiting dilution experiments, a sizable fraction (20 to 40%) of circulating cells spontaneously secreting Ig produced antibody against HIV-1 determinants. The ratio between the two frequencies fitted in very well with the amount of Ig removed from unstimulated culture supernatants after HIV-1-specific antibody absorption with solid-phase HIV-1. These findings indicate that B cell activation during HIV-1 infection is mainly oriented toward a specific response to HIV-1 determinants; the possible relevance of this phenomenon to lymphomagenesis in AIDS patients is discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Core Antigens
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2146-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2476498-Absorption,
pubmed-meshheading:2476498-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:2476498-Adult,
pubmed-meshheading:2476498-B-Lymphocytes,
pubmed-meshheading:2476498-Cells, Cultured,
pubmed-meshheading:2476498-Epitopes,
pubmed-meshheading:2476498-Female,
pubmed-meshheading:2476498-HIV Antibodies,
pubmed-meshheading:2476498-HIV Antigens,
pubmed-meshheading:2476498-HIV-1,
pubmed-meshheading:2476498-Hepatitis Antibodies,
pubmed-meshheading:2476498-Hepatitis B Core Antigens,
pubmed-meshheading:2476498-Herpesvirus 4, Human,
pubmed-meshheading:2476498-Humans,
pubmed-meshheading:2476498-Leukocyte Count,
pubmed-meshheading:2476498-Lymphocyte Activation,
pubmed-meshheading:2476498-Male,
pubmed-meshheading:2476498-Stem Cells
|
pubmed:year |
1989
|
pubmed:articleTitle |
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.
|
pubmed:affiliation |
Institute of Oncology, University of Padova, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|